Physician profile
David E Kang
NPI 1215103403
$11,859.59
in general payments reported to CMS, 2019-2025
51 companies · $1,940 in 2025
The $1,940 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,068 · 2020: $903 · 2021: $1,326 · 2022: $2,485 · 2023: $2,093 · 2024: $2,045 · 2025: $1,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,987 · Travel and Lodging: $62.60 · Education: $29.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,986.83 |
| Travel and Lodging | $62.60 |
| Education | $29.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,351.97 | 2021-2025 | Interstim, Altaviva |
| Urogen Pharma, INC. | $1,299.80 | 2020-2025 | Jelmyto |
| Astellas Pharma US INC | $1,224.98 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Boston Scientific Corporation | $1,134.75 | 2019-2025 | General - Erectile Dysfunction, Lithovue, Ams 700 |
| Sumitomo Pharma America, INC. | $885.75 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $610.35 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $510.33 | 2019-2024 | Xiaflex, Aveed |
| Coloplast Corp | $412.31 | 2019-2025 | Speedicath |
| Dendreon Pharmaceuticals LLC | $405.02 | 2019-2025 | Provenge |
| Laborie Medical Technologies Corp. | $349.74 | 2021-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Abbvie INC. | $335.45 | 2019-2025 | |
| Endo USA, INC. | $322.96 | 2024-2025 | Xiaflex, Aveed |
| Antares Pharma, INC. | $263.69 | 2019-2022 | |
| Calyxo, INC. | $248.07 | 2025 | Cvac Aspiration System |
| Myovant Sciences INC. | $244.64 | 2021-2022 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.